Multicentre results of stereotactic body radiotherapy for secondary liver tumours

HPB

Volumn 15, Issue 11, 2013, Pages 851-857

  Berber, Betul ^a   Ibarra, Rafael ^a   Snyder, Laura ^a   Yao, Min ^a   Fabien, Jeffrey ^a   Milano, Michael T ^b   Katz, Alan W ^b   Goodman, Karyn ^c   Stephans, Kevin ^d   El Gazzaz, Galal ^d   Aucejo, Federico ^d   Miller, Charles ^d   Fung, John ^d   Lo, Simon ^a   MacHtay, Mitchell ^a   Sanabria, Juan ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL TUMOR; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CLINICAL EVALUATION; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GASTROINTESTINAL TUMOR; GROSS TUMOR VOLUME; HUMAN; LIVER INJURY; LIVER METASTASIS; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MEDLINE; MULTICENTER STUDY; OVERALL SURVIVAL; PRIMARY TUMOR; RADIATION DOSE FRACTIONATION; RADIOTHERAPY EQUIPMENT; RETROPERITONEAL TUMOR; STEREOTACTIC BODY RADIATION THERAPY; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME; CLINICAL TRIAL; EPIDEMIOLOGY; INCIDENCE; LIVER NEOPLASMS; LIVER RESECTION; METASTASIS; MIDDLE AGED; MORTALITY; PROCEDURES; RADIOSURGERY; SECONDARY; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS; UNITED STATES; YOUNG ADULT;

ADULT; AGED; FEMALE; HEPATECTOMY; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84886093236     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12044     Document Type: Article

References (31)

1. Silverberg E, Boring CC, Squires TS,. (1990) Cancer statistics. CA Cancer J Clin 40: 9-26.
2. Dawood A, Mahadevan A, Goodman KA,. (2009) Stereotactic body radiation therapy for liver metastases. Eur J Cancer 45: 2947-2949.
3. Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G, et al. (2010) Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 78: 486-493.
4. Goyal K, Einstein D, Yao M, Kunos C, Barton F, Singh D, et al. Cyberknife stereotactic body radiation therapy for non-resectable tumors of the liver: preliminary results. HPB Surg. 2010. Available at http://www.ncbi.nlm.nih.gov/ pubmed/20689733 (last accessed 3 January 2013).
5. Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P,. (2007) Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 67: 793-798.
6. Milano MT, Katz AW, Muhs AG, Philip A, Buchholz D, Schell MC, et al. (2008) A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 112: 650-658.
7. Andolino DL, Johnson CS, Maluccio M, Kwo P, Tector AJ, Zook J, et al. (2011) Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 81: e447-e453.
8. Chan LC, Chiu SK, Chan SL,. (2011) Stereotactic radiotherapy for hepatocellular carcinoma: report of a local single-centre experience. Hong Kong Med J 17: 112-118.
9. Rades D, Hornung D, Veninga T, Schild SE, Gliemroth J,. (2011) Single brain metastasis: radiosurgery alone compared with radiosurgery plus up-front whole-brain radiotherapy. Cancer 118: 2980-2985.
10. Herfarth KK, Debus J, Lohr F, Bahner ML, Wannenmacher M,. (2001) Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 19: 164-170.
11. Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE,. (2005) A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62: 1371-1378.
12. Wulf J, Guckenberger M, Haedinger U, Oppitz U, Mueller G, Baier K, et al. (2006) Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 45: 838-847.
13. McCammon R, Schefter TE, Gaspar LE, Zaemisch R, Gravdahl D, Kavanagh B,. (2009) Observation of a dosecontrol relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 73: 112-118.
14. Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, et al. (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 27: 1579-1584.
15. Kavanagh BD, Schefter TE, Cardenes HR, Stieber VW, Raben D, Timmerman RD, et al. (2006) Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 45: 848-855.
16. Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R, et al. (2009) Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 27: 1585-1591.
17. Gunven P, Blomgren H, Lax I,. (2003) Radiosurgery for recurring liver metastases after hepatectomy. Hepatogastroenterology 50: 1201-1204.
18. Mendez-Romero A, Wunderink W, Hussain SM, De Pooter JA, Heijmen BJ, Nowak PC, et al. (2006) Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i-ii study. Acta Oncol 45: 831-837.
19. Kim MS, Kang JK, Cho CK, Choi CW, Seo YS, Hwang DY, et al. (2009) Three-fraction stereotactic body radiation therapy for isolated liver recurrence from colorectal cancer. Tumori 95: 449-454.
20. van der Pool AE, Mendez Romero A, Wunderink W, Heijmen BJ, Levendag PC, Verhoef C, et al. (2010) Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg 97: 377-382.
21. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216.
22. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45: 228-247.
23. Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S, et al. (2002) Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J Clin Oncol 20: 1499-1505.
24. Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S,. (2006) Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 13: 668-676.
25. Engels B, Everaert H, Gevaert T, Duchateau M, Neyns B, Sermeus A, et al. (2011) Phase II study of helical tomotherapy for oligometastatic colorectal cancer. Ann Oncol 22: 362-368.
26. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, et al. (2009) Multi-institutional phase I/II trial ofstereotactic body radiation therapy for liver metastases. J Clin Oncol 27: 1572-1578.
27. Kim MS, Yoo SY, Cho CK, Yoo HJ, Choi CW, Seo YS, et al. (2009) Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer. Oncology 76: 212-219.
28. Hoyer M, Roed H, Traberg Hansen A, Ohlhuis L, Petersen J, Nelleman H, et al. (2006) Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 45: 823-830.
29. Singletary SE, Walsh G, Vauthey JN, Curley S, Sawaya R, Weber KL, et al. (2003) A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 8: 241-251.
30. Elias D, Maisonnette F, Druet-Cabanac M, Ouellet JF, Grinebetiere JM, Spielmann M, et al. (2003) An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 185: 158-164.
31. Kagara N, Nakano Y, Watanabe A, Inatome J, Nakamura H, Kim C, et al. (2011) Curative-intent stereotactic body radiation therapy for residual breast cancer liver metastasis after systemic chemotherapy. Breast Cancer. Available at http://www.ncbi.nlm.nih.gov/pubmed/21728002 (last accessed 7 January 2013).